Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
At the 2025 Florida Chamber Insurance Summit, Insurance Commissioner Mike Yaworsky announced that Florida’s long‑volatile insurance market has at last regained stability. After a decade marked by runaway litigation, inflated claims, and insurer exits, the sweeping tort and insurance reforms passed in 2022 and 2023 have reversed the decline. Litigation has fallen to pre‑2019 levels, new carriers and reinsurers are entering the state, and consumers now have more options than they’ve seen in years. Yaworsky cautioned, however, that rolling back these reforms would undo the progress and impose massive costs on Floridians.
Driving with an expired license is illegal in nearly every state, and in 2025 the consequences are more serious than most people realize. From fines and potential jail time to denied insurance claims and professional repercussions, even a simple lapse can create a ripple effect—especially for licensed professionals in real estate, insurance, mortgage, and finance. This quick morning read breaks down the real penalties, why professionals should pay attention, and how to renew your license before it becomes a costly mistake.
A new wave of chat‑based AI tools is reshaping how quickly real estate professionals can prepare and enhance listing photos. By simply describing changes—like brightening a kitchen, removing clutter, or fully staging a room—agents and property managers can produce high‑impact images in minutes. This technology not only speeds up market readiness but also boosts renter and buyer engagement by presenting spaces at their full potential from the very first glance.
The rental market is gearing up for major shifts in 2026, from rising compliance demands and surging insurance costs to the rapid adoption of AI‑powered property management tools. Tenants’ expectations are evolving just as quickly, pushing owners to deliver lifestyle‑driven communities rather than simple lease agreements. Investors and operators who embrace technology, stay ahead of regulatory changes and prioritize renter experience will be best positioned to thrive in the coming year.
Artificial intelligence is transforming real estate at lightning speed, turning days of manual work into minutes of automated insight. With the AI real estate market projected to soar from $222.65B in 2024 to over $975B by 2029, professionals who understand this technology now will lead the industry tomorrow. From smarter valuations to automated workflows and predictive analytics, AI is redefining how agents, investors, and property managers operate—making today the perfect time to embrace the tools shaping the future of real estate.
As AI takes over the repetitive tasks that slow agents down, industry expert Matt Britton says the future of real estate belongs to professionals who combine intelligent automation with irreplaceable human trust. Speaking to thousands at NAR NXT 2025, Britton emphasized that the next wave of success will come from agents who embrace AI workflows while doubling down on what technology can’t replicate: empathy, creativity, and meaningful client relationships.
